Wealth Enhancement Advisory Services LLC lifted its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 38.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 41,711 shares of the company's stock after purchasing an additional 11,681 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in Bath & Body Works were worth $1,265,000 as of its most recent filing with the SEC.
Several other large investors have also made changes to their positions in BBWI. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Bath & Body Works by 32.6% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 52,784 shares of the company's stock valued at $2,046,000 after buying an additional 12,964 shares during the period. PNC Financial Services Group Inc. raised its holdings in Bath & Body Works by 5.5% in the 4th quarter. PNC Financial Services Group Inc. now owns 88,423 shares of the company's stock valued at $3,428,000 after acquiring an additional 4,625 shares in the last quarter. Kovitz Investment Group Partners LLC bought a new stake in shares of Bath & Body Works in the 4th quarter worth approximately $258,000. Merit Financial Group LLC acquired a new stake in shares of Bath & Body Works during the 1st quarter worth approximately $714,000. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Bath & Body Works by 13.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,704,625 shares of the company's stock valued at $66,088,000 after purchasing an additional 195,813 shares during the period. Institutional investors and hedge funds own 95.14% of the company's stock.
Analyst Upgrades and Downgrades
BBWI has been the topic of a number of recent research reports. Citigroup lifted their price target on shares of Bath & Body Works from $36.00 to $42.00 and gave the stock a "buy" rating in a research note on Tuesday, May 20th. JPMorgan Chase & Co. raised their price objective on shares of Bath & Body Works from $41.00 to $43.00 and gave the stock an "overweight" rating in a report on Monday, May 19th. Piper Sandler set a $39.00 target price on shares of Bath & Body Works and gave the company an "overweight" rating in a research note on Thursday, May 15th. UBS Group lifted their price objective on Bath & Body Works from $32.00 to $36.00 and gave the company a "neutral" rating in a report on Tuesday, May 20th. Finally, Morgan Stanley dropped their target price on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a report on Tuesday, May 6th. Four research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $42.00.
Read Our Latest Research Report on BBWI
Bath & Body Works Trading Up 1.1%
Shares of Bath & Body Works stock traded up $0.36 during midday trading on Thursday, reaching $33.14. The company had a trading volume of 2,765,646 shares, compared to its average volume of 5,186,184. The stock has a fifty day simple moving average of $29.70 and a 200 day simple moving average of $32.82. Bath & Body Works, Inc. has a 1-year low of $24.94 and a 1-year high of $41.87. The company has a market capitalization of $7.01 billion, a price-to-earnings ratio of 8.84, a price-to-earnings-growth ratio of 1.10 and a beta of 1.72.
Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.02. The business had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.42 billion. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. Bath & Body Works's revenue was up 2.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.38 earnings per share. Sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.
Bath & Body Works Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 6th were given a $0.20 dividend. The ex-dividend date of this dividend was Friday, June 6th. This represents a $0.80 annualized dividend and a dividend yield of 2.41%. Bath & Body Works's dividend payout ratio is presently 21.33%.
Bath & Body Works Company Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Read More

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.